EXALYA S.r.l. – Trademark Portfolio

Entity Type: 99

EXALYA S.r.l. holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 19 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 13 trademarks are registered and 2 are pending. Notable registered marks include TEBI, HONOBAK, CLOSEBAX, ENERPEEL, and ROSACURE.

Località Santigaro, 32

I-25010 San Felice del Benaco (BS)

19 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

EXALYA S.r.l.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (19 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does EXALYA S.r.l. have?

EXALYA S.r.l. has 19 U.S. trademarks filed with the USPTO. Of these, 13 registered, 2 pending, 3 abandoned.

What trademark classes does EXALYA S.r.l. file in?

EXALYA S.r.l. files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are EXALYA S.r.l.'s most well-known trademarks?

EXALYA S.r.l.'s registered trademark portfolio includes well-known marks such as TEBI, HONOBAK, CLOSEBAX, ENERPEEL, and ROSACURE. These are among 13 currently registered trademarks in the portfolio.

What is EXALYA S.r.l.'s trademark registration success rate?

EXALYA S.r.l. has a 81% trademark registration rate, with 13 out of 16 resolved applications resulting in successful registration. Currently, 2 applications are pending review.